Choosing the right path in genome editing – review published in Nature Cell Biology

Genome editing is all about DNA repair. So if you want to get your cells to do more of what you want (*cough* HDR *cough), you’d better know how they make decisions about DNA repair pathways. To help people get the lay of the land, Ph.D. student Charles Yeh and former postdoc Chris Richardson wrote a review all about manipulating DNA repair decisions to influence genome editing outcomes. Out now in Nature Cell Biology!

Be sure to check out Table 1 for a very thorough, non-redundant summary of all the ways people have tried to redirect CRISPR-Cas repair in human cells!

 

SUBMIT A COMMENT

Your email address will not be published. Required fields are marked *

Filters

Latest News

October 22, 2026

New study reveals how PARP can limit prime editing-mediated insertions-published in THE CRISPR JOURNAL

Prime editing enables precise modifications to DNA without introducing double-strand breaks, offering exciting opportunities for genome engineering....

October 15, 2026

CRISPR IN CLINICAL ONCOLOGY: FROM RESEARCH TO CANCER DIAGNOSTICS AND THERAPIES – PUBLISHED IN NATURE REVIEWS CLINICAL ONCOLOGY

CRISPR technologies have transformed biomedical research, opening new possibilities for understanding, diagnosing, and treating cancer. But how close...

October 15, 2026

Choosing the right tool for precise genome editing – published in Nature Reviews Molecular Cell Biology

The genome-editing toolbox is rapidly expanding, offering increasingly diverse ways to make precise changes to DNA. But with so many emerging technologies,...

News Archive